HomeRNXT • NASDAQ
add
RenovoRx Inc
Previous close
$1.40
Day range
$1.36 - $1.41
Year range
$0.75 - $1.69
Market cap
50.84M USD
Avg Volume
192.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 197.00K | — |
Operating expense | 3.21M | 29.77% |
Net income | -2.42M | -124.91% |
Net profit margin | -1.23K | — |
Earnings per share | -0.08 | — |
EBITDA | -3.11M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.58M | 232.24% |
Total assets | 16.01M | 234.46% |
Total liabilities | 2.86M | -5.43% |
Total equity | 13.16M | — |
Shares outstanding | 36.57M | — |
Price to book | 3.89 | — |
Return on assets | -64.44% | — |
Return on capital | -85.46% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.42M | -124.91% |
Cash from operations | -3.38M | -53.40% |
Cash from investing | -2.00K | — |
Cash from financing | 10.81M | 99.46% |
Net change in cash | 7.43M | 130.97% |
Free cash flow | -2.35M | -79.03% |
About
Founded
2009
Website
Employees
10